These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 33563697)
1. Activin A promotes the development of acquired heterotopic ossification and is an effective target for disease attenuation in mice. Mundy C; Yao L; Sinha S; Chung J; Rux D; Catheline SE; Koyama E; Qin L; Pacifici M Sci Signal; 2021 Feb; 14(669):. PubMed ID: 33563697 [TBL] [Abstract][Full Text] [Related]
2. The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator. Lin H; Shi F; Gao J; Hua P Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31341010 [TBL] [Abstract][Full Text] [Related]
3. Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A-Expressing Cell Populations. Mundy C; Yao L; Shaughnessy KA; Saunders C; Shore EM; Koyama E; Pacifici M JBMR Plus; 2023 Dec; 7(12):e10821. PubMed ID: 38130748 [TBL] [Abstract][Full Text] [Related]
4. Activin A does not drive post-traumatic heterotopic ossification. Hwang C; Pagani CA; Das N; Marini S; Huber AK; Xie L; Jimenez J; Brydges S; Lim WK; Nannuru KC; Murphy AJ; Economides AN; Hatsell SJ; Levi B Bone; 2020 Sep; 138():115473. PubMed ID: 32553795 [TBL] [Abstract][Full Text] [Related]
5. Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity. Lees-Shepard JB; Nicholas SE; Stoessel SJ; Devarakonda PM; Schneider MJ; Yamamoto M; Goldhamer DJ Elife; 2018 Sep; 7():. PubMed ID: 30226468 [TBL] [Abstract][Full Text] [Related]
7. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent. Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882 [TBL] [Abstract][Full Text] [Related]
8. Galunisertib attenuates progression of trauma-induced heterotopic ossification via blockage of Smad2/3 signaling in mice. Mao D; Mi J; Pan X; Zhao G; Rui Y Eur J Pharmacol; 2022 Aug; 928():175109. PubMed ID: 35738451 [TBL] [Abstract][Full Text] [Related]
9. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
10. Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs. Maekawa H; Jin Y; Nishio M; Kawai S; Nagata S; Kamakura T; Yoshitomi H; Niwa A; Saito MK; Matsuda S; Toguchida J Orphanet J Rare Dis; 2022 Sep; 17(1):364. PubMed ID: 36131296 [TBL] [Abstract][Full Text] [Related]
11. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. Hino K; Horigome K; Nishio M; Komura S; Nagata S; Zhao C; Jin Y; Kawakami K; Yamada Y; Ohta A; Toguchida J; Ikeya M J Clin Invest; 2017 Sep; 127(9):3339-3352. PubMed ID: 28758906 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma. Strong AL; Spreadborough PJ; Pagani CA; Haskins RM; Dey D; Grimm PD; Kaneko K; Marini S; Huber AK; Hwang C; Westover K; Mishina Y; Bradley MJ; Levi B; Davis TA Bone; 2020 Oct; 139():115517. PubMed ID: 32622875 [TBL] [Abstract][Full Text] [Related]
14. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP). Wang H; Shore EM; Pignolo RJ; Kaplan FS Bone; 2018 Apr; 109():218-224. PubMed ID: 29170109 [TBL] [Abstract][Full Text] [Related]
15. [Fibrodysplasia ossificans progressiva and osteoimmunology]. Katagiri T Clin Calcium; 2016 May; 26(5):691-8. PubMed ID: 27117614 [TBL] [Abstract][Full Text] [Related]
16. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986 [TBL] [Abstract][Full Text] [Related]
17. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. Chakkalakal SA; Shore EM Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice. Wang X; Li F; Xie L; Crane J; Zhen G; Mishina Y; Deng R; Gao B; Chen H; Liu S; Yang P; Gao M; Tu M; Wang Y; Wan M; Fan C; Cao X Nat Commun; 2018 Feb; 9(1):551. PubMed ID: 29416028 [TBL] [Abstract][Full Text] [Related]